卵母细胞捐赠双胎妊娠女性严重孕产妇并发症风险增加
本研究为法国全国性前瞻性队列研究的二次分析,纳入8823例双胎妊娠女性,比较不同受孕方式下严重急性孕产妇并发症(SAMM)风险。医学辅助生殖(MAR)双胎总体SAMM风险较自然受孕高30%,其中自体卵母细胞IVF升高50%,卵母细胞捐赠升高270%。
要点
- 双胎妊娠中,任何类型MAR的SAMM风险均高于自然受孕(aOR 1.3,95%CI 1.1-1.6)。
- 自体卵母细胞IVF(aOR 1.5,95%CI 1.1-1.9)和卵母细胞捐赠(aOR 2.7,95%CI 1.8-4.1)风险升高。
- 非IVF助孕和自体卵母细胞ICSI的SAMM风险与自然受孕无显著差异。
核心结论
- MAR后双胎妊娠女性SAMM风险总体较自然双胎妊娠升高30%,风险因MAR方式而异,自体卵母细胞IVF和卵母细胞捐赠风险更高。
研究设计与样本
- 法国全国性、观察性、前瞻性、基于人群的双胎妊娠队列研究(JUmeaux Mode d'Accouchement)的二次分析,2014年2月10日至2015年3月1日开展;191家符合条件的分娩量超过1500例/年的产科单位中176家(92%)参与,纳入8823例妊娠≥22周分娩的双胎妊娠女性,排除受孕方式未知者75例。
主要发现
- 研究人群8748例中,自然受孕5890例(67.3%),非IVF助孕854例(9.8%),自体卵母细胞IVF 1307例(14.9%),自体卵母细胞ICSI 368例(4.2%),卵母细胞捐赠329例(3.8%);共538例(6.1%)发生SAMM。
- 任何类型MAR后双胎妊娠SAMM风险高于自然双胎妊娠(7.9%(227/2858)vs 5.3%(311/5890),aOR 1.3,95%CI 1.1-1.6)。
- 自体卵母细胞IVF(8.3%;108/1307)和卵母细胞捐赠(14.0%;46/329)的SAMM风险均高于参照组(分别aOR 1.5,95%CI 1.1-1.9和aOR 2.7,95%CI 1.8-4.1),且卵母细胞捐赠高于自体卵母细胞(aOR 1.7,95%CI 1.1-2.6)。
- 非IVF助孕(6.2%;53/854)和自体卵母细胞ICSI(5.4%;20/368)的SAMM风险与参照组(5.3%;311/5890)无显著差异(分别aOR 1.1,95%CI 0.8-1.5和aOR 0.9,95%CI 0.6-1.5)。
- 所检验的中介因素对上述风险升高的解释能力有限。
临床怎么用
- 作者建议,为避免MAR与多胎妊娠高风险组合的不必要暴露,应尽可能鼓励单胚胎移植。
- 作者认为,了解这些差异风险有助于临床医生与女性讨论受孕方式,并有助于优化高风险亚组女性的产科照护。
局限性
- 除分析中考虑的混杂因素和中介因素外,特定的不孕原因和特定的不孕治疗方面可能解释不同受孕方式间SAMM风险的差异,但本研究无这些数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is there a difference in the risk of serious maternal complications during pregnancy and the postpartum in twin pregnancies according to mode of conception: natural conception, non-IVF fertility treatment, IVF, ICSI or oocyte donation? SUMMARY ANSWER: Women with twin pregnancies after medically assisted reproduction (MAR) had an overall risk of serious maternal complications 30% higher compared with women with natural twin pregnancies, and this association varied according to the MAR procedure; the risk was increased by 50% with IVF using autologous oocytes and by 270% with oocyte donation. WHAT IS KNOWN ALREADY: IVF has been reported as a risk factor for serious maternal complications in several concordant studies of singleton pregnancies. For twin pregnancies, this association is less well documented with imprecise categorisation of the mode of conception, and results are contradictory. STUDY DESIGN, SIZE, DURATION: This is a secondary analysis of the national, observational, prospective, population-based cohort study of twin pregnancies (JUmeaux Mode d'Accouchement), which took place in France from 10 February 2014 through 1 March 2015. All French maternity units performing more than 1500 annual deliveries were invited to participate, regardless of their academic, public or private status or level of care. Of the 191 eligible units, 176 (92%) participated. PARTICIPANTS/MATERIALS, SETTING, METHODS: Women with a twin pregnancy who gave birth at or after 22 weeks of gestation were eligible (N = 8823 women included). We excluded women whose mode of conception was unknown (n = 75). Serious maternal complications were regrouped within the recently emerged concept of severe acute maternal morbidity (SAMM), as a binary composite outcome. The exposure of interest was the mode of conception, studied in five classes: natural conception (reference group), non-IVF fertility treatment including insemination and ovarian stimulation, IVF with autologous oocyte, ICSI with autologous oocyte and oocyte donation. To assess the association between the mode of conception and SAMM, we used multivariate logistic regression to adjust for confounders. Structural equation modelling (SEM) was used to explore the contribution to this association of potential intermediate factors, i.e. factors possibly caused by the mode of conception and responsible for SAMM: non-severe pre-eclampsia, placenta praevia and planned mode of delivery. MAIN RESULTS AND THE ROLE OF CHANCE: Among the 8748 women of the study population, 5890 (67.3%) conceived naturally, 854 (9.8%) had non-IVF fertility treatment, 1307 (14.9%) had IVF with autologous oocytes, 368 (4.2%) had ICSI with autologous oocytes and 329 (3.8%) used oocyte donation. Overall, 538 (6.1%) developed SAMM. Women with twin pregnancy after any type of MAR had a higher risk of SAMM than those with a natural twin pregnancy, after adjustment for confounders (7.9% (227/2858) compared to 5.3% (311/5890), adjusted odds ratio (aOR) 1.3, 95% CI 1.1-1.6). This association varied according to the MAR procedure. The risk of SAMM was higher among women with IVF using either autologous oocytes (8.3%; 108/1307) or oocyte donation (14.0%; 46/329) compared with the reference group (respectively aOR 1.5, 95% CI 1.1-1.9 and aOR 2.7, 95% CI 1.8-4.1) and higher after oocyte donation compared with autologous oocytes (aOR 1.7, 95% CI 1.1-2.6). Conversely, the risk of SAMM for women with non-IVF fertility treatment (6.2%; 53/854) and with ICSI using autologous oocytes (5.4%; 20/368) did not differ from that of the reference group (5.3%; 311/5890) (respectively aOR 1.1, 95% CI 0.8-1.5 and aOR 0.9, 95% CI 0.6-1.5). The tested intermediate factors poorly explained these increased risks. LIMITATIONS, REASONS FOR CAUTION: Beyond the confounders and intermediate factors considered in our analysis, specific causes of infertility and specific aspects of infertility treatments may explain the differences in the risk of SAMM by mode of conception. However, these data were not available. WIDER IMPLICATIONS OF THE FINDINGS: Our study showed an increased risk of SAMM in women with twin pregnancies after MAR, notably after IVF using autologous oocytes and particularly after oocyte donation. To avoid unnecessary exposure to the high-risk combination of MAR and multiple pregnancies, transfer of a single embryo should be encouraged whenever possible. Knowledge of these differential risks may inform discussions between clinicians and women about the mode of conception and help to optimise obstetric care for women in subgroups at higher risk. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by a grant from the French Ministry of Health (Programme Hospitalier de Recherche Clinique, AOM2012). There are no competing interests. TRIAL REGISTRATION NUMBER: Not applicable.
引用
- Korb D, Schmitz T, Seco A, et al. Increased risk of severe maternal morbidity in women with twin pregnancies resulting from oocyte donation. Hum Reprod. 2020. PMID: 32644142. doi:10.1093/humrep/deaa108
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。